Hostname: page-component-6bf8c574d5-h6jzd Total loading time: 0.001 Render date: 2025-02-21T05:23:25.614Z Has data issue: false hasContentIssue false
  • English
  • Français

Peer Review of “Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol”

Published online by Cambridge University Press:  02 January 2018

A. L. Johnson  and
D. A. W. Johnson
A. L. Johnson
Affiliation:
University Psychiatric Hospital St Jozef, B-3070 Kortenberg, Belgium
D. A. W. Johnson
Affiliation:
University Psychiatric Hospital St Jozef, B-3070 Kortenberg, Belgium
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The following assessments represent two reviewers' comments on both the original and revised versions of the paper by J. Peuskens on behalf of the Risperidone Study Group. The reviewers were originally anonymous.

Type
Papers
Information
The British Journal of Psychiatry , Volume 166 , Issue 6 , June 1995 , pp. 727 - 733
Copyright
Copyright © Royal College of Psychiatrists, 1995 
Submit a response

eLetters

No eLetters have been published for this article.